FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/103810 [Registered on: 13/02/2026] Trial Registered Prospectively
Last Modified On: 12/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical trial to study the effect of Apamarga Ksharajala spray in patients With dushta vrana . 
Scientific Title of Study   A Randomized controlled clinical trial to evaluate the efficacy of Apamarga Ksharajala Spray in Dushta Vrana. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrAshwini  
Designation  Post graduate scholar , Department of Shalya Tantra 
Affiliation  Shri Dharmastala Manjunatheshwara institute of ayurveda and hospital,Bangalore 
Address  Shri Dharmasthala Manjunatheshwara Institute of Ayurveda and Hospital , Anchepalya , Kumbalagodu post, Bengalore Karnataka 560074 Bengalore Karnataka

Bangalore
KARNATAKA
560074
India 
Phone  9606339469  
Fax    
Email  ashwinigangapure37@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Parvathy S 
Designation  Associate professor  
Affiliation  Shri Dharmastala Manjunatheshwara institute of ayurveda and hospital,Bangalore 
Address  Shri Dharmasthala Manjunatheshwara Institute of Ayurveda and Hospital , Anchepalya , Kumbalagodu post, Bengalore Karnataka 560074 Bengalore Karnataka

Bangalore
KARNATAKA
560074
India 
Phone  9746120528  
Fax    
Email  drparvathy20@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrAshwini  
Designation  Post graduate scholar , Department of Shalya Tantra 
Affiliation  Shri Dharmastala Manjunatheshwara institute of ayurveda and hospital,Bangalore 
Address  Shri Dharmasthala Manjunatheshwara Institute of Ayurveda and Hospital , Anchepalya , Kumbalagodu post, Bengalore Karnataka 560074 Bengalore Karnataka

Bangalore
KARNATAKA
560074
India 
Phone  9606339469  
Fax    
Email  ashwinigangapure37@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Dr ASHWINI 
Address  SDM Institute of Ayurveda and hospital Anchepalya, Kumbalagodu Post, Bengaluru -560074 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrAshwini  Shri Dharmasthala Manjunatheshwara Institute of Ayurveda and Hospital  Shri Dharmasthala Manjunatheshwara Institute of Ayurveda and Hospital ,Anchepalya , Kumbalagodu post, Bengalore Karnataka 560074 Bengalore Karnataka
Bangalore
KARNATAKA 
09606339469

ashwinigangapure37@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC,SDM Institute of Ayurveda and Hospital bangalore   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Approved/Obtained 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L97||Non-pressure chronic ulcer of lower limb, not elsewhere classified. Ayurveda Condition: DUSHTAVRANAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Apamarga ksharajala spray, Reference: sushruta samhita kshara kalpana adhyaya, Route: Topical, Dosage Form: Kshara , Dose: 2(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 8 Days, anupAna/sahapAna: No, Additional Information: -The drug will be applied locally over the cleaned wound once daily for the specified study duration under aseptic precautions.
2Comparator Arm (Non Ayurveda)-Oxum sprayOxum Spray will be applied locally over the infected wound once daily under aseptic precautions for the specified study duration. The spray will be used in sufficient quantity to cover the wound surface as per standard usage guidelines.
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  patients presenting with the features of Dushta vrana , age between 18 to 70 years, irrespective og gender,religion,socioeconomic status and place.
wound size length 5cm,breadth 4cm and depth less than 3cm and chronicity of the ulcer more than 7 days and less than 1 year . 
 
ExclusionCriteria 
Details  Patients aged below 18 years and above 70 years.
Patients suffering from malignancy, tuberculosis, systemic diseases, uncontrolled diabetes mellitus, leprosy, deep vein thrombosis, or hepatitis B.
Pregnant and lactating women. 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Changes in the status of the Dushta Vrana,Reduction of pain
and tenderness. 
Day 1 (Before treatment)

Day 8 (After treatment )
 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in the Quality of Life.  Day 1 (Before treatment)

Day 8 (After treatment )
 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   16/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This study is a randomized, parallel group, active-controlled clinical trial designed to evaluate the efficacy of Apamarga Ksharajala Spray in the management of Dushta Vrana. A total of 30 patients fulfilling the diagnostic and inclusion criteria of Dushta Vrana will be randomly allocated into two groups. Group A will receive Apamarga Ksharajala Spray, while Group B will receive Oxum spray as the control intervention. The treatment will be administered locally over the wound for a specified duration as per the study protocol.
The assessment of wound healing will be carried out using the Bates–Jensen Wound Assessment Tool, along with evaluation of pain and tenderness. Quality of life will be assessed as a secondary outcome. The study aims to scientifically evaluate the wound cleansing and healing potential of Apamarga Ksharajala Spray and to compare its efficacy with the control intervention. The data obtained will be statistically analyzed to determine the therapeutic effectiveness of the intervention. All patient information will be kept confidential, and the study will be conducted following ethical guidelines.
 
Close